VNDA — Vanda Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $244.87m
- $82.02m
- $216.11m
Brief: EMA's CHMP Recommends Extension Of Therapeutic Indication For Pfizer's Hympavzi
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy
U.S. STOCKS ON THE MOVE-Pinterest, Best Buy, Dave
Vanda rises after FDA grants rare hearing on jet‑lag drug bid
Brief: Vanda Announces FDA Grants Landmark Hearing For Hetlioz® In Jet Lag Disorder, The First Drug Approval Hearing In Over 40 Years
Brief: EMA's CHMP Recommended Granting A Marketing Authorisation For Mcombriax
U.S. STOCKS ON THE MOVE -Viatris, Clear Secure, Bicara
U.S. STOCKS ON THE MOVE-Sharps Technology, Whirlpool, Applovin
U.S. STOCKS ON THE MOVE-Oracle, Vanda, Keysight
Vanda rises after FDA accepts application to review rare skin disease drug
Brief: Vanda Pharmaceuticals Announces FDA Acceptance Of Biologics License Application Filing For Imsidolimab For The Treatment Of Generalized Pustular Psoriasis
U.S. STOCKS ON THE MOVE-AbbVie, CrowdStrike, PayPal
U.S. STOCKS ON THE MOVE-Enhabit, Ethos Technologies, gold miners
U.S. STOCKS ON THE MOVE-Merck, Alphabet, JPMorgan Chase
U.S. STOCKS ON THE MOVE-Eli Lilly, Domino's, Novo Nordisk
Vanda Pharma jumps as US FDA approves new antipsychotic pill
NASDAQ RESUMED AT 07:50 PM
Vanda surges after FDA approval for antipsychotic drug